InvestorsHub Logo
Followers 45
Posts 5645
Boards Moderated 0
Alias Born 04/05/2015

Re: exwannabe post# 300897

Wednesday, 08/19/2020 8:26:13 AM

Wednesday, August 19, 2020 8:26:13 AM

Post# of 700909
Just a reminder that NICE gave a positive rec on one of the Car-T's within days of that drugs approval.

They are not slower than the EMA.

In theory, the idea is to dovetail the two processes, so that NICE reports very soon after a marketing approval is granted.

I'm sure it doesn't always work as seamlessly as that. But it certainly can do, if NICE decide to prioritise, due to a recognition of an urgent unmet clinical need.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News